On April 24, 2018, the FDA’s Center for Tobacco Products (CTP) sent a letter to San Francisco-based Juul Labs, addressing the recent media attention surrounding youth usage of the popular vaping products.

“Juul product use appears to be common in middle and high schools based on widespread media reporting describing a rapid growth of use among youth in general, numerous complaints that have been received by CTP, small research studies that have raised concerns and social-media evidence of youth use,” the letter read. “Their appeal may be related to different aspects of the product, including the product design, promotion or distribution, and CTP seeks information to further understand the appeal and use.”

The CTP gave Juul a deadline of June 19, 2018, to submit a number of documents to help the agency better understand youth usage. The requested information includes, but is not limited to:

—Documents related to product marketing.
—Documents related to research on product design (as it may relate to the appeal or addictive potential for youth).
—Consumer complaints associated with the products.

Photo courtesy of vaping360.com/juul/juul-vapor-review/